Familial colorectal cancer screening: When and what to do?

查看全文 作　　者：Giovanna Del Vecchio [1]Blanco;Omero Alessandro [1]Paoluzi;Pierpaolo [1,2]Sileri;Piero [1,3]Rossi;Giuseppe [1,2]Sica;Francesco [1]Pallone

机构地区：[1]Department of Systems Medicine,Gastroenterology Unit,University Tor Vergata;[2]Department of Surgery,University Tor Vergata;[3]Department of Experimental Science and Surgery,University Tor Vergata

出　　处：《World Journal of Gastroenterology》索引2015年第21卷第26期,共10页

摘　　要：Colorectal cancer(CRC) is the third leading cause of death worldwide and represents a clinical challenge.Family members of patients affected by CRC have an increased risk of CRC development.In these individuals,screening is strongly recommended and should be started earlier than in the population with average risk,in order to detect neoplastic precursors,such as adenoma,advanced adenoma,and nonpolypoid adenomatous lesions of the colon.Fecal occult blood test(FOBT) is a non invasive,widespread screening method that can reduce CRC-related mortality.Sigmoidoscopy,alone or in addition to FOBT,represents another screening strategy that reduces CRC mortality.Colonoscopy is the best choice for screening highrisk populations,as it allows simultaneous detection and removal of preneoplastic lesions.The choice of test depends on local health policy and varies among countries. 关键词：COLONOSCOPY Colorectal cancer SCREENING FECAL OCCULT blood test Advanced ADENOMA Firstdegreerelative SIGMOIDOSCOPY

相关文献

参考文献（90）
引证文献（3）
耦合文献（0）

参考文献(90)

引证文献(3)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Familial colorectal cancer screening: When and what to do?

参考文献(90)

引证文献(3)

用户提示